<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8820653</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35132408</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8820653</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1101/2022.02.01.478677</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1.</table-label><table-caption>Clinical information detailed by symptom severity and medical treatment of COVID participants.The table shows the number and percentages of participants based on two clinical categories. The first three rows show number and percentage of participants by symptom severity and the last five rows are based on the type of medication administered and the requirement of O2 support. Particularly, information from 9 participants could not be obtained as these participants did not agree to share the symptom publicly/anonymously. Keys: No. Aff. = number of affected patients, No Info. = no information available because these patients did not give consent to share symptom information, Data Avail. = number of subjects with clinical assessment data available, No. Tot. = total number of patients including those with no information available, % Out of Avail. = proportion of patients affected vs patients with clinical assessment data available (n = 38) in percentages, % Out of Total = proportion of patients affected vs. total number of patients (n = 47) in percentages, O2 = oxygen supplied to support breathing, BiPap = bilevel positive air pressure, Mix Medications* = a combination of medications – Dexamethasone, Ceftriaxone and Clexane injections</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1.</label><caption><title>Clinical information detailed by symptom severity and medical treatment of COVID participants.</title><p id="P48">The table shows the number and percentages of participants based on two clinical categories. The first three rows show number and percentage of participants by symptom severity and the last five rows are based on the type of medication administered and the requirement of O<sub>2</sub> support. Particularly, information from 9 participants could not be obtained as these participants did not agree to share the symptom publicly/anonymously. <bold>Keys:</bold> No. Aff. = number of affected patients, No Info. = no information available because these patients did not give consent to share symptom information, Data Avail. = number of subjects with clinical assessment data available, No. Tot. = total number of patients including those with no information available, % Out of Avail. = proportion of patients affected vs patients with clinical assessment data available (n = 38) in percentages, % Out of Total = proportion of patients affected vs. total number of patients (n = 47) in percentages, O<sub>2</sub> = oxygen supplied to support breathing, BiPap = bilevel positive air pressure, Mix Medications* = a combination of medications – Dexamethasone, Ceftriaxone and Clexane injections</p></caption><table frame="box" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Clinical Category</th><th align="left" valign="middle" rowspan="1" colspan="1">Assessment/Treatment</th><th align="left" valign="middle" rowspan="1" colspan="1">No. Aff.</th><th align="left" valign="middle" rowspan="1" colspan="1">No Info.</th><th align="left" valign="middle" rowspan="1" colspan="1">Data Avail.</th><th align="left" valign="middle" rowspan="1" colspan="1">No. Tot.</th><th align="left" valign="middle" rowspan="1" colspan="1">% Out of Avail.</th><th align="left" valign="middle" rowspan="1" colspan="1">% Out of Total</th></tr></thead><tbody><tr><td rowspan="3" align="left" valign="top" colspan="1">Symptom Severity</td><td align="left" valign="top" rowspan="1" colspan="1">Mild</td><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">44.74</td><td align="left" valign="top" rowspan="1" colspan="1">36.17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">10.53</td><td align="left" valign="top" rowspan="1" colspan="1">8.51</td></tr><tr style="border-bottom: solid 1px"><td align="left" valign="top" rowspan="1" colspan="1">Moderate-Severe</td><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">44.74</td><td align="left" valign="top" rowspan="1" colspan="1">36.17</td></tr><tr><td rowspan="5" align="left" valign="top" colspan="1">Medication &amp; O<sub>2</sub> Support</td><td align="left" valign="top" rowspan="1" colspan="1">Remdesivir</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">26.32</td><td align="left" valign="top" rowspan="1" colspan="1">21.28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Additional O<sub>2</sub></td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">13.16</td><td align="left" valign="top" rowspan="1" colspan="1">10.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BiPap &amp; Actemra</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">2.63</td><td align="left" valign="top" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mix Medications*</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">2.63</td><td align="left" valign="top" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antibiotic &amp; Steroid</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">2.63</td><td align="left" valign="top" rowspan="1" colspan="1">2.13</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical information detailed by symptom severity and medical treatment of COVID participants.The table shows the number and percentages of participants based on two clinical categories. The first three rows show number and percentage of participants by symptom severity and the last five rows are based on the type of medication administered and the requirement of O2 support. Particularly, information from 9 participants could not be obtained as these participants did not agree to share the symptom publicly/anonymously. Keys: No. Aff. = number of affected patients, No Info. = no information available because these patients did not give consent to share symptom information, Data Avail. = number of subjects with clinical assessment data available, No. Tot. = total number of patients including those with no information available, % Out of Avail. = proportion of patients affected vs patients with clinical assessment data available (n = 38) in percentages, % Out of Total = proportion of patients affected vs. total number of patients (n = 47) in percentages, O2 = oxygen supplied to support breathing, BiPap = bilevel positive air pressure, Mix Medications* = a combination of medications – Dexamethasone, Ceftriaxone and Clexane injections</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="groups"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><thead><tr><th align="left" valign="middle">Clinical Category</th><th align="left" valign="middle">Assessment/Treatment</th><th align="left" valign="middle">No. Aff.</th><th align="left" valign="middle">No Info.</th><th align="left" valign="middle">Data Avail.</th><th align="left" valign="middle">No. Tot.</th><th align="left" valign="middle">% Out of Avail.</th><th align="left" valign="middle">% Out of Total</th></tr></thead><tbody><tr><td rowspan="3" align="left" valign="top">Symptom Severity</td><td align="left" valign="top">Mild</td><td align="left" valign="top">17</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">44.74</td><td align="left" valign="top">36.17</td></tr><tr><td align="left" valign="top">Moderate</td><td align="left" valign="top">4</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">10.53</td><td align="left" valign="top">8.51</td></tr><tr style="border-bottom: solid 1px"><td align="left" valign="top">Moderate-Severe</td><td align="left" valign="top">17</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">44.74</td><td align="left" valign="top">36.17</td></tr><tr><td rowspan="5" align="left" valign="top">Medication &amp; O2 Support</td><td align="left" valign="top">Remdesivir</td><td align="left" valign="top">10</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">26.32</td><td align="left" valign="top">21.28</td></tr><tr><td align="left" valign="top">Additional O2</td><td align="left" valign="top">5</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">13.16</td><td align="left" valign="top">10.64</td></tr><tr><td align="left" valign="top">BiPap &amp; Actemra</td><td align="left" valign="top">1</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">2.63</td><td align="left" valign="top">2.13</td></tr><tr><td align="left" valign="top">Mix Medications*</td><td align="left" valign="top">1</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">2.63</td><td align="left" valign="top">2.13</td></tr><tr><td align="left" valign="top">Antibiotic &amp; Steroid</td><td align="left" valign="top">1</td><td align="left" valign="top">9</td><td align="left" valign="top">38</td><td align="left" valign="top">47</td><td align="left" valign="top">2.63</td><td align="left" valign="top">2.13</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2:</table-label><table-caption>Group level statistics on participant demographics among HC and COVID group.The table shows the test results from participant demographics including age, sex and fatigue. There was no significant differences in age and sex between the two groups. However, the COVID group experienced significantly higher fatigue levels compared to HC group. Keys:p = p-value, t = two-sample t-test statistic, χ2= Chi-Squared statistic, T = Wilcoxon Rank Sum test score, M = Male, F = Female.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>Table 2:</label><caption><title>Group level statistics on participant demographics among HC and COVID group.</title><p id="P49">The table shows the test results from participant demographics including age, sex and fatigue. There was no significant differences in age and sex between the two groups. However, the COVID group experienced significantly higher fatigue levels compared to HC group. <bold>Keys:</bold><italic toggle="yes">p = p-value, t = two-sample t-test statistic, χ</italic><sup>2</sup>= <italic toggle="yes">Chi-Squared statistic, T = Wilcoxon Rank Sum test score,</italic> M = Male, F = Female.</p></caption><table frame="box" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Measures</th><th align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th><th align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">stat</italic></th><th align="left" valign="top" rowspan="1" colspan="1">HC, mean (SD)</th><th align="left" valign="top" rowspan="1" colspan="1">COVID, mean (SD)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.66</td><td align="left" valign="middle" rowspan="1" colspan="1">−0.44 <italic toggle="yes">(t)</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">33.50 (9.74)</td><td align="left" valign="middle" rowspan="1" colspan="1">34.63 (11.54)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td align="left" valign="middle" rowspan="1" colspan="1">0.38</td><td align="left" valign="middle" rowspan="1" colspan="1">0.76 <italic toggle="yes">(χ</italic><sup>2</sup><italic toggle="yes">)</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">23M, 7F</td><td align="left" valign="middle" rowspan="1" colspan="1">31M, 15F</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fatigue</td><td align="left" valign="middle" rowspan="1" colspan="1">2.097e-07</td><td align="left" valign="middle" rowspan="1" colspan="1">36.5 <italic toggle="yes">(T)</italic></td><td align="left" valign="middle" rowspan="1" colspan="1">0.65 (0.79)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.93 (1.21)</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 2:<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Group level statistics on participant demographics among HC and COVID group.The table shows the test results from participant demographics including age, sex and fatigue. There was no significant differences in age and sex between the two groups. However, the COVID group experienced significantly higher fatigue levels compared to HC group. Keys:p = p-value, t = two-sample t-test statistic, χ2= Chi-Squared statistic, T = Wilcoxon Rank Sum test score, M = Male, F = Female.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="groups"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><thead><tr><th align="left" valign="top">Measures</th><th align="left" valign="top">p</th><th align="left" valign="top">stat</th><th align="left" valign="top">HC, mean (SD)</th><th align="left" valign="top">COVID, mean (SD)</th></tr></thead><tbody><tr><td align="left" valign="middle">Age (years)</td><td align="left" valign="middle">0.66</td><td align="left" valign="middle">−0.44 (t)</td><td align="left" valign="middle">33.50 (9.74)</td><td align="left" valign="middle">34.63 (11.54)</td></tr><tr><td align="left" valign="middle">Sex</td><td align="left" valign="middle">0.38</td><td align="left" valign="middle">0.76 (χ2)</td><td align="left" valign="middle">23M, 7F</td><td align="left" valign="middle">31M, 15F</td></tr><tr><td align="left" valign="middle">Fatigue</td><td align="left" valign="middle">2.097e-07</td><td align="left" valign="middle">36.5 (T)</td><td align="left" valign="middle">0.65 (0.79)</td><td align="left" valign="middle">2.93 (1.21)</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3.</table-label><table-caption>List of spatial regions from significant clusters obtained from the contrast – COVID &gt; HC.The regions from three RSNs – BGN, PRN and LANG which demonstrated significant differences are presented with peak MNI coordinates (X Y Z) and corresponding peak t-score values for each cluster. Keys: ΔFC = Direction of change in Functional Connectivity; Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; Peak t = peak t-score; pFWE = family wise error corrected p-value.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T3"><label>Table 3.</label><caption><title>List of spatial regions from significant clusters obtained from the contrast – COVID &gt; HC.</title><p id="P50">The regions from three RSNs – <italic toggle="yes">BGN</italic>, <italic toggle="yes">PRN</italic> and <italic toggle="yes">LANG</italic> which demonstrated significant differences are presented with peak MNI coordinates (X Y Z) and corresponding <italic toggle="yes">peak t</italic>-score values for each cluster. <bold>Keys:</bold> ΔFC = Direction of change in Functional Connectivity; Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; Peak <italic toggle="yes">t</italic> = <italic toggle="yes">peak t</italic>-score; <italic toggle="yes">p</italic><sub><italic toggle="yes">FWE</italic></sub> = family wise error corrected p-value.</p></caption><table frame="box" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">ΔFC</th><th align="left" valign="top" rowspan="1" colspan="1">RSN Name</th><th align="left" valign="top" rowspan="1" colspan="1">Cl. No.</th><th align="left" valign="top" rowspan="1" colspan="1">Anatomical Locations</th><th align="left" valign="top" rowspan="1" colspan="1">Cl. Size</th><th colspan="3" align="left" valign="top" rowspan="1">Peak MNI Coordinates</th><th align="left" valign="top" rowspan="1" colspan="1">Peak <italic toggle="yes">t</italic></th><th align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub><italic toggle="yes">fwe</italic></sub></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">X</th><th align="left" valign="top" rowspan="1" colspan="1">Y</th><th align="left" valign="top" rowspan="1" colspan="1">Z</th><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">COVID &gt; HC</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">BGN</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Right</italic> – <italic toggle="yes">Calcarine Cortex (Calc)</italic><break/><italic toggle="yes">Right</italic> – <italic toggle="yes">Cuneus (Cun)</italic><break/><italic toggle="yes">Right</italic> – <italic toggle="yes">Lingual Gyrus (LiG)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">69</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">−84</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">4.46</td><td align="left" valign="top" rowspan="1" colspan="1">0.004</td></tr><tr style="border-bottom: solid 1px"><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">PRN</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Right</italic> – <italic toggle="yes">Superior Parietal Lobule (SPL)</italic><break/><italic toggle="yes">Right</italic> – <italic toggle="yes">Precuneus (PCu)</italic><break/><italic toggle="yes">Left</italic> – <italic toggle="yes">Superior Parietal Lobule (SPL)</italic><break/><italic toggle="yes">Left</italic> – <italic toggle="yes">Precuneus (PCu)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">−57</td><td align="left" valign="top" rowspan="1" colspan="1">54</td><td align="left" valign="top" rowspan="1" colspan="1">4.22</td><td align="left" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HC &gt; COVID</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">LANG</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Right</italic> – <italic toggle="yes">Cerebellar Exterior (CExt.)</italic><break/><italic toggle="yes">Right</italic> – <italic toggle="yes">Cerebellar Vermal Lobules I-V</italic><break/><italic toggle="yes">Right</italic> – <italic toggle="yes">Cerebellar Vermal Lobules VI-VII</italic></td><td align="left" valign="top" rowspan="1" colspan="1">57</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">−63</td><td align="left" valign="top" rowspan="1" colspan="1">−24</td><td align="left" valign="top" rowspan="1" colspan="1">3.56</td><td align="left" valign="top" rowspan="1" colspan="1">0.019</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">List of spatial regions from significant clusters obtained from the contrast – COVID &gt; HC.The regions from three RSNs – BGN, PRN and LANG which demonstrated significant differences are presented with peak MNI coordinates (X Y Z) and corresponding peak t-score values for each cluster. Keys: ΔFC = Direction of change in Functional Connectivity; Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; Peak t = peak t-score; pFWE = family wise error corrected p-value.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="groups"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><thead><tr><th align="left" valign="top">ΔFC</th><th align="left" valign="top">RSN Name</th><th align="left" valign="top">Cl. No.</th><th align="left" valign="top">Anatomical Locations</th><th align="left" valign="top">Cl. Size</th><th colspan="3" align="left" valign="top">Peak MNI Coordinates</th><th align="left" valign="top">Peak t</th><th align="left" valign="top">pfwe</th></tr><tr><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top">X</th><th align="left" valign="top">Y</th><th align="left" valign="top">Z</th><th align="left" valign="top"/><th align="left" valign="top"/></tr></thead><tbody><tr><td align="left" valign="top">COVID &gt; HC</td><td align="left" valign="top">BGN</td><td align="left" valign="top">1</td><td align="left" valign="top">Right – Calcarine Cortex (Calc)Right – Cuneus (Cun)Right – Lingual Gyrus (LiG)</td><td align="left" valign="top">69</td><td align="left" valign="top">9</td><td align="left" valign="top">−84</td><td align="left" valign="top">6</td><td align="left" valign="top">4.46</td><td align="left" valign="top">0.004</td></tr><tr style="border-bottom: solid 1px"><td align="left" valign="top"/><td align="left" valign="top">PRN</td><td align="left" valign="top">1</td><td align="left" valign="top">Right – Superior Parietal Lobule (SPL)Right – Precuneus (PCu)Left – Superior Parietal Lobule (SPL)Left – Precuneus (PCu)</td><td align="left" valign="top">90</td><td align="left" valign="top">21</td><td align="left" valign="top">−57</td><td align="left" valign="top">54</td><td align="left" valign="top">4.22</td><td align="left" valign="top">0.001</td></tr><tr><td align="left" valign="top">HC &gt; COVID</td><td align="left" valign="top">LANG</td><td align="left" valign="top">1</td><td align="left" valign="top">Right – Cerebellar Exterior (CExt.)Right – Cerebellar Vermal Lobules I-VRight – Cerebellar Vermal Lobules VI-VII</td><td align="left" valign="top">57</td><td align="left" valign="top">9</td><td align="left" valign="top">−63</td><td align="left" valign="top">−24</td><td align="left" valign="top">3.56</td><td align="left" valign="top">0.019</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>T4</table-id><table-label>Table 4.</table-label><table-caption>List of spatial regions from the cluster showing significant correlation with self-reported fatigue among COVID individuals.The regions from PRN which demonstrated significant correlation are presented with peak MNI coordinates (X Y Z) and corresponding peak t-score values for each cluster. Keys: FC = Functional Connectivity; ftg. = Fatigue Scores, Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; t = peak t-score; pFDR = false discovery rate corrected p-value.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T4"><label>Table 4.</label><caption><title>List of spatial regions from the cluster showing significant correlation with self-reported fatigue among COVID individuals.</title><p id="P51">The regions from <italic toggle="yes">PRN</italic> which demonstrated significant correlation are presented with peak MNI coordinates (X Y Z) and corresponding peak <italic toggle="yes">t</italic>-score values for each cluster. <bold>Keys:</bold> FC = Functional Connectivity; ftg. = Fatigue Scores, Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; <italic toggle="yes">t</italic> = peak <italic toggle="yes">t</italic>-score; <italic toggle="yes">p</italic><sub><italic toggle="yes">FDR</italic></sub> = false discovery rate corrected p-value.</p></caption><table frame="box" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Corr (FC, ftg.)</th><th align="left" valign="top" rowspan="1" colspan="1">RSN Name</th><th align="left" valign="top" rowspan="1" colspan="1">Cl. No.</th><th align="left" valign="top" rowspan="1" colspan="1">Anatomical Locations</th><th align="left" valign="top" rowspan="1" colspan="1">Cl. Size</th><th colspan="3" align="left" valign="top" rowspan="1">Peak MNI Coordinates</th><th align="left" valign="top" rowspan="1" colspan="1">Peak <italic toggle="yes">t</italic></th><th align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub><italic toggle="yes">FDR</italic></sub></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">X</th><th align="left" valign="top" rowspan="1" colspan="1">Y</th><th align="left" valign="top" rowspan="1" colspan="1">Z</th><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">COVID</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">PRN</italic></td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Left – Superior Parietal Lobule (SPL)</italic><break/><italic toggle="yes">Left – Superior Occipital Gyrus (SOG)</italic><break/><italic toggle="yes">Left – Angular Gyrus (AnG)</italic><break/><italic toggle="yes">Left – Precuneus (PCu)</italic></td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">−21</td><td align="left" valign="top" rowspan="1" colspan="1">−72</td><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">4.40</td><td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.05</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 4.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">List of spatial regions from the cluster showing significant correlation with self-reported fatigue among COVID individuals.The regions from PRN which demonstrated significant correlation are presented with peak MNI coordinates (X Y Z) and corresponding peak t-score values for each cluster. Keys: FC = Functional Connectivity; ftg. = Fatigue Scores, Cl. = Cluster; Cl. No. = Number of Clusters; Cl. Size = Cluster Size; t = peak t-score; pFDR = false discovery rate corrected p-value.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="groups"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><thead><tr><th align="left" valign="top">Corr (FC, ftg.)</th><th align="left" valign="top">RSN Name</th><th align="left" valign="top">Cl. No.</th><th align="left" valign="top">Anatomical Locations</th><th align="left" valign="top">Cl. Size</th><th colspan="3" align="left" valign="top">Peak MNI Coordinates</th><th align="left" valign="top">Peak t</th><th align="left" valign="top">pFDR</th></tr><tr><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top">X</th><th align="left" valign="top">Y</th><th align="left" valign="top">Z</th><th align="left" valign="top"/><th align="left" valign="top"/></tr></thead><tbody><tr><td align="left" valign="top">COVID</td><td align="left" valign="top">PRN</td><td align="left" valign="top">1</td><td align="left" valign="top">Left – Superior Parietal Lobule (SPL)Left – Superior Occipital Gyrus (SOG)Left – Angular Gyrus (AnG)Left – Precuneus (PCu)</td><td align="left" valign="top">46</td><td align="left" valign="top">−21</td><td align="left" valign="top">−72</td><td align="left" valign="top">42</td><td align="left" valign="top">4.40</td><td align="left" valign="top">&lt; 0.05</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>